NASDAQ · TBRG

TruBridge, Inc.

$26.24 $0.00 (+0.00%) 1D

Key Metrics

$331.25M
Market cap
7,047.84×
P/E · TTM
−$937.00K
Revenue · TTM
$47.00K
Net income
EPS · TTM $0.00
Dividend yield
Free cash flow
Beta · 1Y 0.66
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 23
    The stock moved +12.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 23
  • Apr 13
    The stock moved +18.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 13
  • Mar 30
    From its Feb 4 high, the share price fell 37%.

    Peak close $22.06 on Feb 4; trough close $14.00 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -37%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$331.25M
Enterprise value$459.68M
Shares outstanding15.0M
52-wk range$13.88 – $26.51
Avg volume · 20D156.8K
Net cash −$128.43M
Book value / share$12.43
IndustryServices-Computer Programming Services
ExchangeNASDAQ
About TruBridge, Inc.
IPO dateMay 21, 2002
Employees3200

TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E7,047.84
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №$0.96

Profitability

Gross
Operating 544.5%
Net -5.0%
FCF
ROE / ROIC 0.0% · —

Financial Health

Current ratio1.78
Quick ratio1.77
Debt / equity0.92
Debt / EBITDA
Net cash −$128.43M
Working capital$48.20M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

0.9
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$0.96 vs $26.24
Trades 27.4× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings